MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹249 Cr | ₹155 Cr | ₹123 Cr | ₹98 Cr | ₹80 Cr |
What is the latest Long Term Provisions ratio of MANKIND PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹249 Cr |
| Mar2025 | ₹155 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹98 Cr |
| Mar2022 | ₹80 Cr |
How is Long Term Provisions of MANKIND PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹249 Cr | 60.36 | |
| Mar2025 | ₹155 Cr | 25.94 | |
| Mar2024 | ₹123 Cr | 25.78 | |
| Mar2023 | ₹98 Cr | 22.36 | |
| Mar2022 | ₹80 Cr | - | |
Compare Long Term Provisions of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹95,072.6 Cr | 2.2% | -6.5% | -10.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,780.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,828.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,305.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,759.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.2% |
-6.5% |
-10.5% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses